0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Effect of Amantadine on Prolactin Secretion, Pituitary DNA Synthesis and 3H-Spiperone Binding in Male Estrogen-Treated Rats

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Amantadine, a well-known antiviral agent, causing an increase in dopamine synthesis, release and the inhibition of re-uptake of noradrenaline and dopamine in central and peripheral catecholaminergic neurons, is successfully used in the treatment of Parkinson’s disease. In the present paper, we have studied the effect of various doses of amantadine on in vivo prolactin secretion and the incorporation of <sup>3</sup>H-thymidine and <sup>3</sup>H-spiperone binding by the anterior pituitary gland of long-term diethylstil-boestrol-treated male Wistar rats. Four weeks after a subcutaneous implantation of Silastic tubes containing 10 mg of diethylstil-boestrol, a dramatic rise in serum prolactin levels was observed, accompanied by an increased uptake of <sup>3</sup>H-thymidine by DNA anterior pituitary cells. Amantadine, given in the subcutaneous doses of 50, 5 and 0.5 mg/kg of body weight attenuated the stimulatory effect of stilboestrol on serum prolactin concentration in a dose-dependent fashion. On the other hand, the incorporation of <sup>3</sup>H-thymidine into DNA pituitary cells in all the groups of amantadine-treated rats was only slightly suppressed. In an additional experiment, Scatchard analyses were performed on the in vitro <sup>3</sup>H-spiperone binding kinetics in a dispersed anterior pituitary cell culture prepared from the pituitaries of 6-week diethylstilboestrol-treated rats. It has been found that amantadine injected in the dose of 5 mg/kg of body weight for 14 days induced a twofold decrease in the density of dopamine D<sub>2</sub> binding sites (36.6 ± 9.4 vs. 70.3 ± 3.4 fmol/l0<sup>6</sup> cells; p < 0.02), while the apparent affinity of the receptors was unchanged. It is concluded then that the inhibitory effect of amantadine on pituitary prolactin cell function seems to be related to the modulation of synthesis and release of dopamine from hypothalamic dopaminergic neurons and to the down-regulation of dopaminergic D<sub>2</sub> binding sites within the anterior pituitary gland.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1990
          1990
          03 April 2008
          : 51
          : 6
          : 632-636
          Affiliations
          aInstitute of Endocrinology and b Department of Neurosurgery, University School of Medicine, Lodz, Poland
          Article
          125403 Neuroendocrinology 1990;51:632–636
          10.1159/000125403
          2141919
          © 1990 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Categories
          Original Paper

          Comments

          Comment on this article